Skip to main content

IOANNIS GRIVEAS

MD,PhD

Presentations

  • 152. Hydration Status And Phase Angle Estimation By Multifrequency Bioimpedance In Patients With Chronic Kidney Disease
    Ioannis Griveas
    Private Renal Clinic “Athens - Nephrology”
    XIX International Congress on Nutrition and Metabolism in Renal Disease (ICRNM 2018) Genova, Italy - June 26/30, 2018
  • 153. EFFICACY AND SAFETY OF ETECALCETIDE A NOVEL INTRAVENOUS CALCIMIMETIC FOR SECONDARY HYPERPARATHYROIDISM IN HEMODIALYSIS PATIENTS: REAL LIFE DATA
    Ioannis Griveas
    Private Renal Clinic “Athens - Nephrology”
    56th ERA EDTA Congress, Budapest 13-16 June 2019
  • 154. EFFECT O CITRATE BASED DIALYSATE ON INTRADIALYTIC HEPARIN DOSEIN MAINTENANCE HEMODIALYSIS PATIENTS
    Ioannis Griveas
    Private Renal Clinic “Athens - Nephrology”
    56th ERA EDTA Congress, Budapest 13-16 June 2019
  • 155. "PACLITAXEL-COATED BALLOON ANGIOPLASTY FOR STENOSIS OF ARTERIOVENOUS FISTULA IN PATIENTS UNDER HEMODIALYSIS"
    I. Griveas, G. Vourliotakis, I Kantounakis, et al.
    417 Army Share Fund Hospital of Athens, Greece
    21st Hellenic Nephrology Congress, Delphi 29 May - 1 June, 2020
  • 156. ΕFFICACY AND SAFETY OF USING ETELCALCETIDE IN PATIENTS WITH END –STAGE RENAL DISEASE UNDER HEMODIALYSIS AND MIBNERAL BONE RENAL DISEASE
    I. Griveas, M Aktsiali, C. Andriopoulos, P Sitaras T Papachrisanthou
    Private Dialysis Unit “Nefroiatriki”, Athens, Greece
    417 Army Share Fund Hospital of Athens, Greece
    21st Hellenic Nephrology Congress, Delphi 29 May - 1 June, 2019
  • 157. Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients after 10 months therapy
    I. Griveas
    417 Army Share Fund Hospital, Athens, Greece
    ASN-Renal week , Washington DC, 5-10 November 2019
  • 158. Tumoral Calcinosis in hemodialysis patient
    I. Griveas
    417 Army Share Fund Hospital, Athens, Greece
    ASN-Renal week , Washington DC, 5-10 November 2019
  • 159. The Importance of monitoring blood flow in the maintenance of vascular access in patients under hemodialysis
    I. Griveas
    417 Army Share Fund Hospital, Athens, Greece
    ASN-Renal week , Washington DC, 5-10 November 2019
  • 160. "USE OF ASCORBATE-RICH DIALYSATE IN HEMODIALYSIS PATIENTS"
    I. Griveas
    417 Army Share Fund Hospital, Athens, Greece
    57th ERA-EDTA Congress, Milan June 6-9, 2020)
  • 161. "PACLITAXEL-COATED BALLOON ANGIOPLASTY FOR STENOSIS OF ARTERIOVENOUS FISTULA IN PATIENTS UNDER HEMODIALYSIS: 18TH MONTH FOLLOW-UP"
    I. Griveas, G. Vourliotakis, I Kantounakis, et al.
    417 Army Share Fund Hospital, Athens, Greece
    57th ERA-EDTA Congress, Milan June 6-9, 2020)
  • 162. SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AND COVID-19 INFECTION IN HEMODIALYSIS PATIENTS
    I.Griveas
    417 Army Share Fund Hospital of Athens, Greece
    58th ERA-EDTA Congress, Berlin June 5-8, 2021
  • 163. COVID-19 INFECTION IN HEMODIALYSIS PATIENTS:FINDINGS-EXPERIENCE-OUTCOME
    I.Griveas
    417 Army Share Fund Hospital of Athens, Greece
    58th ERA-EDTA Congress, Berlin June 5-8, 2021
  • 164. HEMOPERFUSION IN HEMODIALYSIS PATIENTS WITH COVID-19 INFECTION: IMPACT ON CLINICAL COURSE
    I.Griveas
    417 Army Share Fund Hospital of Athens, Greece
    58th ERA-EDTA Congress, Berlin June 5-8, 2021
  • 165. EFFECTIVESS OF HEMOPERFUSION ON HEMODIALYSIS(HD) PATIENTS WITH COVID-19I NFECTION
    I.Griveas*,E.Pratilas,G.Asimakopoulos
    Nephrology Department Army Share Fund Hospital of Athens, Greece(417NIMTS)
    39th Vicenza Course on AKI and CRRT, 26-29 October 2021
  • 166. SmartPD™ Automated Peritoneal Dialysis System as a New Sophisticated Choice for Urgent Integration in Replacement Therapy for a Patient with ESRD
    Ioannis Griveas.
    Army Share Fund Hospital of Athens, 417 NIMTS, Athens, Greece.
    ASN-Renal Week , San Diego , 4-7 November 2021